News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Endo To Announce First Quarter 2014 Financial Results On May 1, 2014



4/16/2014 6:30:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DUBLIN, April 15, 2014 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) will announce its first quarter 2014 financial results before the open of the U.S. financial markets on May 1, 2014 and members of its senior management team will host a conference call and webcast at 7:30 a.m. ET that day.

Investors and other interested parties may call (866)-318-8612 (domestic) or (617)-399-5131 (international) and enter passcode 77043540. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from May 1, 2014 at 10:00 a.m. ET until 11:59 p.m. ET on May 8, 2014 by dialing (888)-286-8010 (domestic) or (617)-801-6888 (international) and entering passcode 27504760.

A simultaneous webcast of the call can be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 11:59 p.m. ET on May 8, 2014. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo International plc
Endo International plc is a global specialty healthcare company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets, and distributes quality branded pharmaceutical, generic and device products through its operating companies. Endo has global headquarters in Dublin, Ireland and US headquarters in Malvern, PA. Learn more at www.endo.com.

SOURCE Endo International plc



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES